FRNM

9.3605.69%
RW

Randal W. Scott

Independent Director

Mr. Randal W. Scott, also known as Randy, Ph.D., is Director of Station-X, Inc. He is Co-Founder & Chairman of Genome Medical Holding Company. He is Independent Director of Freenome, Inc. from February 2018. He is Independent Director of Talis Biomedical Corporation from February 2016. He is Chairman & CEO of Genomic Life, Inc. He was Co-Founder of Initiate Studios, LLC until 2026. He was employed at Initiate Studios, LLC until 2026. He was Co-Founder & Chairman of the Board of Invitae Corporation from July 18, 2022 to August 7, 2024. He was Executive Chairman of Invitae Corporation from January 09, 2017 to September 01, 2019. He was employed at Invitae Corporation from 2010 to August 7, 2024. He was Director of Genomic Health, Inc. He was employed at Genomic Health, Inc. from August 2000 to March 01, 2012. He was Chairman, President, Chief Scientific Officer and Secretary of Incyte Corporation. He was employed at Incyte Corporation from April 1991 to August 2000. He was Director of Diadexus, Inc. He joined the Diadexus, Inc. in September 1997. He was Chairman and Chief Executive Officer of Invitae Corporation. He joined the Invitae Corporation on August 08, 2012. He was Director of Freenome Limited from December 21, 2017. He joined the Freenome Limited on December 21, 2017. He was Independent Director of BridgeBio Pharma, Inc. from June 2020 to June 22, 2026. He was employed at BridgeBio Pharma, Inc. from June 2020 to June 22, 2026. Scott was a Founder of Incyte Corporation. He is on the board of Talis Biomedical Corporation, BridgeBio and Freenome. He served as the Chairman and Chief Executive Officer at Locus Development Inc. since August 8, 2012. Early in his career, Randy held roles with Invitron and Unigene Laboratories. Scott is a prominent thought leader in the genomics and sequencing space and has been a featured speaker at events globally. He is the author of several publications, patents and is the recipient of numerous awards which highlight his leadership in the personalized medicine space, including Distinguished Alumni Awards from The University of Kansas and Emporia State University, the Genome Technology Magazine 2001 All-Star award and the Forbes Biotech's Top 25 Influential Insiders in 1999. In 1997, he received the Ernst & Young/NASDAQ Silicon Valley Entrepreneur of the Year for Life Sciences award. Mr. Scott has Ph.D. in Biochemistry from University of Kansas and B.S. in Chemistry from Emporia State University.

Positions